MARKET

ADCT

ADCT

Adc Therapeutics Sa
NYSE
4.130
-0.220
-5.06%
After Hours: 4.050 -0.08 -1.94% 19:28 03/13 EDT
OPEN
4.360
PREV CLOSE
4.350
HIGH
4.560
LOW
4.120
VOLUME
815.86K
TURNOVER
--
52 WEEK HIGH
4.980
52 WEEK LOW
1.050
MARKET CAP
524.69M
P/E (TTM)
-3.6796
1D
5D
1M
3M
1Y
5Y
1D
RBC Capital Sticks to Their Buy Rating for ADC Therapeutics (ADCT)
TipRanks · 2d ago
Guggenheim Sticks to Their Buy Rating for ADC Therapeutics (ADCT)
TipRanks · 3d ago
ADC Therapeutics (ADCT) Loss Narrowing To US$0.04 EPS Challenges Bearish Profitability Narrative
Simply Wall St · 3d ago
ADC Therapeutics files to sell 9.83M common shares for holders
TipRanks · 3d ago
ADC Therapeutics Narrows Losses, Supported By Higher Product Revenue And Ongoing Restructuring
NASDAQ · 4d ago
ADC Therapeutics outlines $600M–$1B peak revenue target for ZYNLONTA as LOTIS-5 and LOTIS-7 advance
Seeking Alpha · 4d ago
ADC Therapeutics SA (ADCT) Reports Q4 Loss, Tops Revenue Estimates
NASDAQ · 4d ago
ADC Therapeutics Posts Narrower Loss In Q4
NASDAQ · 4d ago
More
About ADCT
ADC Therapeutics SA is a Switzerland-based clinical-stage oncology drug discovery and development company. It develops antibody drug conjugates (ADCs) for the treatment of both solid and hematological cancers. It employs monoclonal antibodies specific to particular tumor antigens conjugated to a class of pyrrolobenzodiazepine (PBD)-based warheads to selectively target and kill cancer cells. The Company has multiple PBD-based ADCs in ongoing clinical trials, ranging from first in human to pivotal Phase II clinical trials, and numerous preclinical ADCs in development. Its main drug candidates are ADCT-301 for the treatment of lymphoma and leukemia and ADCT-402 for the treatment of non-Hodgkin’s lymphoma and B-cell leukemia. It serves customers in the United States, Switzerland, and the United Kingdom.

Webull offers ADC Therapeutics SA stock information, including NYSE: ADCT real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ADCT stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ADCT stock methods without spending real money on the virtual paper trading platform.